Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report
- 31 January 2001
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 37 (1), 47-53
- https://doi.org/10.1016/s0959-8049(00)00369-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- What has been learned from measuring health-related quality of life in clinical oncologyEuropean Journal Of Cancer, 1999
- Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: Long-Term SurvivalGynecologic Oncology, 1999
- Perceptions of Cisplatin-Related Toxicity among Ovarian Cancer Patients and Gynecologic OncologistsGynecologic Oncology, 1998
- Palliative therapy in advanced ovarian cancerAnti-Cancer Drugs, 1998
- Quality of life in patients with ovarian cancer: Current state of researchSupportive Care in Cancer, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancerQuality of Life Research, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Improving the Quality of Life during Chemotherapy for Advanced Breast CancerNew England Journal of Medicine, 1987
- Coefficient alpha and the internal structure of testsPsychometrika, 1951